Literature DB >> 23436071

Comment on Mertens et al.: Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.

John S Fleming, Livia Tossici-Bolt, Matthew Guy, Paul Kemp.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23436071     DOI： 10.1007/s00259-013-2364-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  The specific uptake size index for quantifying radiopharmaceutical uptake.

Authors:  John S Fleming; Livia Bolt; Jennifer S Stratford; Paul M Kemp
Journal:  Phys Med Biol       Date:  2004-07-21       Impact factor: 3.609

2.  Calibration of gamma camera systems for a multicentre European ¹²³I-FP-CIT SPECT normal database.

Authors:  Livia Tossici-Bolt; John C Dickson; Terez Sera; Robin de Nijs; Maria Claudia Bagnara; Catherine Jonsson; Egon Scheepers; Felicia Zito; Anita Seese; Pierre Malick Koulibaly; Ozlem L Kapucu; Michel Koole; Maria Raith; Jean George; Markus Nowak Lonsdale; Wolfgang Münzing; Klaus Tatsch; Andrea Varrone
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

3.  Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.

Authors:  Jeroen Mertens; André Dobbeleir; Hamphrey Ham; Yves D'Asseler; Ingeborg Goethals; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

4.  Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio.

Authors:  Livia Tossici-Bolt; Sandra M A Hoffmann; Paul M Kemp; Rajnikant L Mehta; John S Fleming
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-21       Impact factor: 10.057
  4 in total
  2 in total

1.  Prognostic value of metabolic parameters and clinical impact of ¹⁸F-fluorocholine PET/CT in biochemical recurrent prostate cancer.

Authors:  M Colombié; L Campion; C Bailly; D Rusu; T Rousseau; C Mathieu; L Ferrer; N Rousseau; F Kraeber-Bodéré; C Rousseau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-21       Impact factor: 9.236

2.  Standardized added metabolic activity (SAM) IN ¹⁸F-FDG PET assessment of treatment response in colorectal liver metastases.

Authors:  Jeroen Mertens; S De Bruyne; N Van Damme; P Smeets; W Ceelen; R Troisi; S Laurent; K Geboes; M Peeters; I Goethals; C Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-01       Impact factor: 9.236
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.